Radiographic Progression Without Corresponding Prostate-specific Antigen Progression in Patients with Metastatic Castration-sensitive Prostate Cancer Receiving Apalutamide: Secondary Analysis of the TITAN TrialWataru Fukuokaya, Takahiro Kimura, Paweł Rajwa et al.|European Urology Oncology|2024Cited by 25
Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration‐sensitive prostate cancerWataru Fukuokaya, Akihiro Hirakawa, Keiichiro Mori et al.|Cancer|2025Cited by 3